Benjamin A Lopman

InstitutionEmory University
AddressAtlanta
Georgia
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 21 Covid-19 publications, with a maximum of 6 publications in July 2021
    All Publications
    Bar chart showing 171 publications over 19 distinct years, with a maximum of 18 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Liu CY, Berlin J, Kiti MC, Del Fava E, Grow A, Zagheni E, Melegaro A, Jenness SM, Omer SB, Lopman B, Nelson K. Rapid Review of Social Contact Patterns During the COVID-19 Pandemic. Epidemiology. 2021 11 01; 32(6):781-791. PMID: 34392254.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    2. Lopman BA, Shioda K, Nguyen Q, Beckett SJ, Siegler AJ, Sullivan PS, Weitz JS. A framework for monitoring population immunity to SARS-CoV-2. Ann Epidemiol. 2021 11; 63:75-78. PMID: 34425208.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Jenness SM, Willebrand KS, Malik AA, Lopman BA, Omer SB. Dynamic network strategies for SARS-CoV-2 control on a cruise ship. Epidemics. 2021 12; 37:100488. PMID: 34438256.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    4. Wang Y, Siesel C, Chen Y, Lopman B, Edison L, Thomas M, Adams C, Lau M, Teunis PFM. Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Georgia, USA, February 1-July 13, 2020. Emerg Infect Dis. 2021 10; 27(10):2578-2587. PMID: 34399085.
      Citations:    Fields:    Translation:HumansPHPublic Health
    5. Lamba K, Bradley H, Shioda K, Sullivan PS, Luisi N, Hall EW, Mehrotra ML, Lim E, Jain S, Kamali A, Sanchez T, Lopman BA, Fahimi M, Siegler AJ. SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California. Open Forum Infect Dis. 2021 Aug; 8(8):ofab379. PMID: 34377733.
      Citations:    
    6. Citations: 3     Fields:    Translation:Humans
    7. Sullivan PS, Siegler AJ, Shioda K, Hall EW, Bradley H, Sanchez T, Luisi N, Valentine-Graves M, Nelson KN, Fahimi M, Kamali A, Sailey C, Lopman BA. SARS-CoV-2 cumulative incidence, United States, August-December 2020. Clin Infect Dis. 2021 Jul 10. PMID: 34245245.
      Citations:    Fields:    
    8. Kraay ANM, Han P, Kambhampati AK, Wikswo ME, Mirza SA, Lopman BA. Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported By 9 US States. J Infect Dis. 2021 07 02; 224(1):9-13. PMID: 33606027.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    9. Shioda K, Lau MSY, Kraay ANM, Nelson KN, Siegler AJ, Sullivan PS, Collins MH, Weitz JS, Lopman BA. Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies. Epidemiology. 2021 07 01; 32(4):518-524. PMID: 33935138.
      Citations: 14     Fields:    Translation:Humans
    10. Lewnard JA, Patel MM, Jewell NP, Verani JR, Kobayashi M, Tenforde MW, Dean NE, Cowling BJ, Lopman BA. Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines. Epidemiology. 2021 07 01; 32(4):508-517. PMID: 34001753.
      Citations: 10     Fields:    Translation:Humans
    11. Kiti MC, Aguolu OG, Liu CY, Mesa AR, Regina R, Woody M, Willebrand K, Couzens C, Bartelsmeyer T, Nelson KN, Jenness S, Riley S, Melegaro A, Ahmed F, Malik F, Lopman BA, Omer SB. Social contact patterns among employees in 3 U.S. companies during early phases of the COVID-19 pandemic, April to June 2020. Epidemics. 2021 09; 36:100481. PMID: 34171510.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    12. Kraay ANM, Hayashi MAL, Berendes DM, Sobolik JS, Leon JS, Lopman BA. Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices. Emerg Infect Dis. 2021 04; 27(4):1229-1231. PMID: 33755002.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    13. Lopman B, Liu CY, Le Guillou A, Handel A, Lash TL, Isakov AP, Jenness SM. A modeling study to inform screening and testing interventions for the control of SARS-CoV-2 on university campuses. Sci Rep. 2021 03 15; 11(1):5900. PMID: 33723312.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    14. Jacob JT, Baker JM, Fridkin SK, Lopman BA, Steinberg JP, Christenson RH, King B, Leekha S, O'Hara LM, Rock P, Schrank GM, Hayden MK, Hota B, Lin MY, Stein BD, Caturegli P, Milstone AM, Rock C, Voskertchian A, Reddy SC, Harris AD. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel. JAMA Netw Open. 2021 03 01; 4(3):e211283. PMID: 33688967.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    15. Howard-Anderson JR, Adams C, Sherman AC, Dube WC, Smith TC, Edupuganti N, Chea N, Magill SS, Espinoza DO, Zhu Y, Phadke VK, Edupuganti S, Steinberg JP, Lopman BA, Jacob JT, Collins MH, Fridkin SK. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A cross-sectional analysis of subjects enrolled in the COVID-19 Prevention in Emory Healthcare Personnel (COPE) study. Infect Control Hosp Epidemiol. 2021 Feb 09; 1-6. PMID: 33557990.
      Citations: 2     Fields:    
    16. Baker JM, Nelson KN, Overton E, Lopman BA, Lash TL, Photakis M, Jacob JT, Roback JD, Fridkin SK, Steinberg JP. Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System. Ann Intern Med. 2021 05; 174(5):649-654. PMID: 33513035.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    17. Gallagher ME, Sieben AJ, Nelson KN, Kraay ANM, Orenstein WA, Lopman B, Handel A, Koelle K. Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. Nat Med. 2021 01; 27(1):4-5. PMID: 33230343.
      Citations: 6     Fields:    Translation:Humans
    18. Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proc Natl Acad Sci U S A. 2020 09 08; 117(36):22430-22435. PMID: 32820074.
      Citations: 44     Fields:    Translation:HumansCellsPHPublic Health
    19. Siegler AJ, Sullivan PS, Sanchez T, Lopman B, Fahimi M, Sailey C, Frankel M, Rothenberg R, Kelley CF, Bradley H. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response. Ann Epidemiol. 2020 09; 49:50-60. PMID: 32791199.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    Lopman's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (175)
    Explore
    _
    Co-Authors (176)
    Explore
    _
    Similar People (60)
    Explore
    _